Arcutis Biotherapeutics

ARQT61

$11.45arrow_drop_down0.47%-$0.05

ARQT61

$11.45

arrow_drop_down0.47%-$0.05

Performance History

Key Stats
Open	$11.54
Prev. Close	$11.51
EPS	-1.77
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	11.41	11.54
52 Week Range	1.76	13.17

Ratios







EPS	-1.77

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Arcutis Biotherapeutics (ARQT)

Arcutis Biotherapeutics Inc (ARQT) is a biopharmaceutical company focused on developing innovative therapies for the treatment of dermatological conditions. The company's mission is to improve the lives of patients suffering from skin diseases by delivering high-quality, differentiated therapies. With a strong pipeline of potential treatments, Arcutis is well-positioned to address unmet needs in the dermatology market.

One of the key factors that investors consider when evaluating a stock is its price history. In the case of Arcutis Biotherapeutics, the stock price has shown significant volatility over the past year. It experienced a sharp decline in March 2020 due to the COVID-19 pandemic, but has since rebounded and reached new highs. The stock has also been subject to fluctuations in response to news and developments related to the company's pipeline and clinical trials.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Todd Franklin Watanabe M.A.
Headquarters: Westlake Village
Employees: 268
Exchange: NASDAQ

add Arcutis Biotherapeutics to watchlist

Keep an eye on Arcutis Biotherapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Arcutis Biotherapeutics 's (ARQT) price per share?

The current price per share for Arcutis Biotherapeutics (ARQT) is $11.46. The stock has seen a price change of -$0.05 recently, indicating a -0.48% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Arcutis Biotherapeutics (ARQT)?

For Arcutis Biotherapeutics (ARQT), the 52-week high is $13.17, which is 14.97% from the current price. The 52-week low is $1.76, the current price is 550.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Arcutis Biotherapeutics (ARQT) a growth stock?

Arcutis Biotherapeutics (ARQT) has shown an average price growth of -3.4% over the past three years. It has received a score of 93 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Arcutis Biotherapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Arcutis Biotherapeutics (ARQT) stock price performance year to date (YTD)?

As of the latest data, Arcutis Biotherapeutics (ARQT) has a year-to-date price change of 233.97%. Over the past month, the stock has experienced a price change of 31.52%. Over the last three months, the change has been 8.27%. Over the past six months, the figure is 29%.

help

Is Arcutis Biotherapeutics (ARQT) a profitable company?

Arcutis Biotherapeutics (ARQT) has a net income of -$262.14M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 91.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -87.29% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $59.61M, although specific revenue growth data is currently not available. The gross profit is $54.62M. Operating income is noted at -$241.1M. Furthermore, the EBITDA is -$179.41M.

help

What is the market capitalization of Arcutis Biotherapeutics (ARQT)?

Arcutis Biotherapeutics (ARQT) has a market capitalization of $1.35B. The average daily trading volume is 11.53, indicating the stock's liquidity and investor engagement.